Forty Years with Coronaviruses
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Retroactive News.2017
Newsletter of the Center for Retrovirus Research at The Ohio State University 2017 Highlights Dr. Li Wu awarded NIH R01 to study how RNA modifications modulate retroviral infection Dr. Li Wu has been awarded a replication in CD4+ T-cells by affecting the structure, new $1.42 million R01 grant from stability, splicing, and/or trafficking of HIV-1 RNA. NIH to investigate how HIV-1 Investigations of the HIV-1 RNA m6A modification and RNA modifications modulate viral interactions with host proteins represent a new area infection. of HIV-1 RNA biology which can potentially facilitate In this project, Dr. Wu and his therapeutic development against HIV-1 infection. collaborators will study the Dr. Wu’s collaborators in this project include Dr. Chuan molecular mechanisms by which He at University of Chicago and Howard Hughes Medical 6 6 N -methyladenosine (m A) Institute, Drs. Karin Musier-Forsyth and Mark Foster at modification of HIV-1 RNA regulates The Ohio State University, and Dr. Mamuka Kvaratskhelia viral replication in CD4+ T-cells. They hypothesize that at the University of Colorado. reversible m6A modification of HIV-1 RNA regulates viral Dr. Namal Liyanage, PhD joins the Ohio State faculty and the CRR Dr. Namal Liyanage was recruited during the ALVAC-SIV prime boost vaccination strategy to join the Departments of Microbial in collaboration with Dr. Rafick-Pierre Sekaly, at Case Infection and Immunity and Western Reserve University. Veterinary Biosciences, and the Dr. Liyanage is the recipient of a 2016 NIH career Center for Retrovirus Research transition grant (K22 Award). Dr. Liyanage’s lab at Ohio (CRR), as part of the university’s State mainly focuses on understanding the role of the Discovery Themes initiative. -
Article Download (79)
wjpls, 2020, Vol. 6, Issue 6, 152-161 Review Article ISSN 2454-2229 Pratik et al. World Journal of Pharmaceutical World Journaland Life of Pharmaceutica Sciencesl and Life Science WJPLS www.wjpls.org SJIF Impact Factor: 6.129 THE NOVEL CORONAVIRUS (COVID-19) CAUSATIVE AGENT FOR HUMAN RESPIRATORY DISEASES Pratik V. Malvade1*, Rutik V. Malvade2, Shubham P. Varpe3 and Prathamesh B. Kadu3 1Pravara Rural College of Pharmacy, Pravaranagar, 413736, Dist. - Ahmednagar (M.S.) India. 2Pravara Rural Engineering College, Loni, 413736, Dist. - Ahmednagar (M.S.) India. 3Ashvin College Of Pharmacy, Manchi Hill, Ashvi Bk., 413714, Dist.- Ahmednagar (M.S.) India. *Corresponding Author: Pratik V. Malvade Pravara Rural College of Pharmacy, Pravaranagar, 413736, Dist. - Ahmednagar (M.S.) India. Article Received on 08/04/2020 Article Revised on 29/04/2020 Article Accepted on 19/05/2020 ABSTRACT The newly founded human coronavirus has named as Covid-19. The full form of Covid-19 is “Co-Corona, vi- virus and d- disease”. The Covid-19 is also named as 2019-nCoV because of it was firstly identified at the end of 2019. The coronavirus are the group of various types of viruses i.e. some have positive-sense, single stranded RNA and they are covered within the envelope made up of protein. Still now days seven human coronaviruses are identified are Nl 63, 229E, OC43, HKU1, SARS-CoV, MERS-CoV and latest Covid-19 also known as SARS-CoV-2. From above all, the SARS-CoV and MERS-CoV causes the highest outbreak but the outbreak of Covid-19 is much more than the other any virus. -
COVID-19) Outbreak in Algeria: a New Challenge for Prevention
Open Access Journal of Community Medicine & Health Care Review Article Novel Coronavirus Disease 2019 (COVID-19) Outbreak in Algeria: A New Challenge for Prevention Boukhatem MN* Département de Biologie et Physiologie Cellulaire, Faculté Abstract des Sciences de la Nature et de la Vie, Université - Saad In December 2019, the novel Coronavirus Disease 2019 (COVID-19) Dahlab - Blida 1, Blida, Algeria outbreak started in Wuhan, the capital of Hubei province in China. Since then *Corresponding author: Mohamed Nadjib it has spread to many other continents and regions, including low-income BOUKHATEM, Département de Biologie et Physiologie countries. With the current trajectory of the 2019-nCoV outbreak unknown, Cellulaire, Faculté des Sciences de la Nature et de la Vie, medical measures and public health will both be needed to contain spreading of Université – Saad Dahlab – Blida 1, Blida, Algeria; Email: the 2019-nCoV and to improve patient outcomes. [email protected] It is imperative to increase attentiveness of tourists and travelers about the Received: March 24, 2020; Accepted: March 31, dangers and suitable protective recommendations and for health professionals 2020; Published: April 07, 2020 to be attentive and vigilant if a patient with pneumonia or severe respiratory symptoms reports a recent history of travel to the country affected with SARS- CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Preventive measures should be taken by National and local health authorities of the affected countries, including Algeria, in order to increase hospital hygiene and desinfection. Finally, it is fundamental to explore the explanations for people’s poor compliance with recommendations and rules and to take exact measures in order to improve them. -
And the New Coronavirus (SARS-Cov-2)
General characteristics of the Human Coronavirus (HCoVs) and the new coronavirus (SARS-CoV-2) that produces COVID-19 illness. Dora Rosete1, Gabriel Cortez1, and Carlos Guti´errez2 1National Institute of Respiratory Diseases 2Affiliation not available September 11, 2020 Abstract The new coronavirus has been named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible of the COVID- 19 illness, it is a virus that belongs to the Coronavirus family, it is the third virus in this family that causes an epidemic. It originated in China and has spread throughout the world. It is highly pathogenic and transmissible that mainly affects the respiratory tract and can cause death. There is not antiviral drug or vaccines against COVID-19 illness, infected person only have supportive treatments. Recently, some antiviral drugs and vaccines are being valued. In this review, we described the general characteristics of HCoVs and latest research of the transmission, prevention and clinical characteristics of SARS-CoV-2 and some treatments and vaccines more development for to combat COVID-19 illness. General characteristics of the Human Coronavirus (HCoVs) and the new coronavirus (SARS- CoV-2) that produces COVID-19 illness. Dora Patricia Rosete-Olvera, Gabriel Palma-Cort´es,Carlos Cabello-Guti´errez. Department of Research in Virology and Mycology, National Institute of Respiratory Diseases. Ismael Cos´ıo Villegas (INER), Calzada de Tlalpan No. 4502, Colonia Secci´onXVI. Tlalpan 14080, M´exicoCDMX. Correspondence M en C Dora Patricia Rosete Olvera Department of Research in Virology and Mycology National Institute of Respiratory Diseases, Ismael Cos´ıoVillegas, CDMX. Email: [email protected] Phone: 55 54 87 17 00. -
Alignment-Free Machine Learning Approaches for the Lethality Prediction of Potential Novel Human-Adapted Coronavirus Using Genomic Nucleotide
bioRxiv preprint doi: https://doi.org/10.1101/2020.07.15.176933; this version posted July 15, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Alignment-free machine learning approaches for the lethality prediction of potential novel human-adapted coronavirus using genomic nucleotide Rui Yin1,*, Zihan Luo2, Chee Keong Kwoh1 1 Biomedical Informatics Lab, Nanyang Technological University, Singapore, Singapore 2 School of Electronic Information and Communications, Huazhong University of Science and Technology, Wuhan, Hubei Province, China * [email protected] Abstract A newly emerging novel coronavirus appeared and rapidly spread worldwide and World 1 Health Organization declared a pandemic on March 11, 2020. The roles and 2 characteristics of coronavirus have captured much attention due to its power of causing 3 a wide variety of infectious diseases, from mild to severe on humans. The detection of 4 the lethality of human coronavirus is key to estimate the viral toxicity and provide 5 perspective for treatment. We developed alignment-free machine learning approaches for 6 an ultra-fast and highly accurate prediction of the lethality of potential human-adapted 7 coronavirus using genomic nucleotide. We performed extensive experiments through six 8 different feature transformation and machine learning algorithms in combination with 9 digital signal processing to infer the lethality of possible future novel coronaviruses 10 using previous existing strains. The results tested on SARS-CoV, MERS-Cov and 11 SARS-CoV-2 datasets show an average 96.7% prediction accuracy. -
Chain Maturation and Surface Expression Heavy Μ and D Μ
Conventional and Surrogate Light Chains Differentially Regulate Ig µ and Dµ Heavy Chain Maturation and Surface Expression This information is current as Terry Fang, Brendan P. Smith and Christopher A. J. Roman of October 5, 2021. J Immunol 2001; 167:3846-3857; ; doi: 10.4049/jimmunol.167.7.3846 http://www.jimmunol.org/content/167/7/3846 Downloaded from References This article cites 73 articles, 34 of which you can access for free at: http://www.jimmunol.org/content/167/7/3846.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on October 5, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2001 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Conventional and Surrogate Light Chains Differentially Regulate Ig and D Heavy Chain Maturation and Surface Expression1 Terry Fang, Brendan P. Smith, and Christopher A. J. Roman2 Positive selection of precursor (pre-) B cells by Ig membrane H chains (m HC) and counterselection mediated by the truncated HC D depend on the ability of each HC to form a pre-B cell receptor (pre-BCR) signaling complex with the surrogate L chain (SLC) components 5 and Vpre-B. -
Genome-Wide Rnai Screen Identifies Broadly-Acting Host Factors That Inhibit Arbovirus Infection." Plos Pathogens.10,2
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 Genome-wide RNAi screen identifies broadly- acting host factors that inhibit arbovirus infection Ari Yasunaga University of Pennsylvania Sheri L. Hanna University of Pennsylvania Jianqing Li Washington University School of Medicine in St. Louis Hyelim Cho Washington University School of Medicine in St. Louis Patrick P. Rose University of Pennsylvania See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Yasunaga, Ari; Hanna, Sheri L.; Li, Jianqing; Cho, Hyelim; Rose, Patrick P.; Spiridigliozzi, Anna; Gold, Beth; Diamond, Michael S.; and Cherry, Sara, ,"Genome-wide RNAi screen identifies broadly-acting host factors that inhibit arbovirus infection." PLoS Pathogens.10,2. e1003914. (2014). https://digitalcommons.wustl.edu/open_access_pubs/2700 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Ari Yasunaga, Sheri L. Hanna, Jianqing Li, Hyelim Cho, Patrick P. Rose, Anna Spiridigliozzi, Beth Gold, Michael S. Diamond, and Sara Cherry This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/2700 Genome-Wide RNAi Screen Identifies Broadly-Acting Host Factors That Inhibit -
Pharmatab 014.Pdf
NEWS LETTER . JUNE 2020 .VOLUME 1 . ISSUE 14 Bharathi Priya K, Shailaja K, Leena Muppa, Magimai Upagara Valan UPDATES ON DRUG TARGETS FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS 2 (SARS-COV-2) Dr. S.Parasuraman, Associate Professor & Unit Head Pharmacology, AIMST University, Bedong, Malaysia Viruses are obligate intracellular parasites negative regulator of the RAAS system other antivirals, chloroquine is in phase I and and they do not carry out metabolic (downregulation of ACE2 directly affects phase II trials[5]. processes. Viruses utilize most of the cardiovascular function)[2] ACE2 inhibition The clinical eficacy of the enhanced platelet physiological machinery of the host and few induces ADAM17 gene expression, leading to inhibition, trypsin inhibitor, monoclonal drugs inhibiting viral replication without the release of tumor necrosis factor α (TNFα) antibodies, immunomodulator, Natural killer affecting the host cells. and cytokines such as interleukin 4 (IL-4) and cells, an immunosuppressive drug, and In 2019, Severe acute respiratory syndrome interferon γ (IFNγ); [3] increased cytokine vaccine also under the investigation. Globally, coronavirus 2 (SARS-CoV-2) is identiied concentrations activate further pro- about 3.4% of COVID-19 cases have died, and which is positive-sense single-stranded inlammatory pathways, leading to a cytokine the disease spreading can be prevented by ribonucleic acid (RNA) virus. SARS-CoV-2 is storm and [4] personal hygiene and by social distancing to the strain of beta-coronavirus which causes ADAM-17 also promotes the cleavage of ACE2 break the COVID chain. coronavirus disease 2019 (COVID-19), receptors. Anti-coronavirus therapies divided References: responsible for the COVID-19 pandemic. -
The COVID-19 Pandemic: a Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
Journal of Clinical Medicine Review The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control Yosra A. Helmy 1,2,* , Mohamed Fawzy 3,*, Ahmed Elaswad 4, Ahmed Sobieh 5, Scott P. Kenney 1 and Awad A. Shehata 6,7 1 Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, OH 44691, USA; [email protected] 2 Department of Animal Hygiene, Zoonoses and Animal Ethology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt 3 Department of Virology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt 4 Department of Animal Wealth Development, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt; [email protected] 5 Department of Radiology, University of Massachusetts Medical School, Worcester, MA 01655, USA; [email protected] 6 Avian and Rabbit Diseases Department, Faculty of Veterinary Medicine, Sadat City University, Sadat 32897, Egypt; [email protected] 7 Research and Development Section, PerNaturam GmbH, 56290 Gödenroth, Germany * Correspondence: [email protected] (Y.A.H.); [email protected] (M.F.) Received: 18 March 2020; Accepted: 21 April 2020; Published: 24 April 2020 Abstract: A pneumonia outbreak with unknown etiology was reported in Wuhan, Hubei province, China, in December 2019, associated with the Huanan Seafood Wholesale Market. The causative agent of the outbreak was identified by the WHO as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), producing the disease named coronavirus disease-2019 (COVID-19). The virus is closely related (96.3%) to bat coronavirus RaTG13, based on phylogenetic analysis. -
Download Program
Oral Program Sunday, October 1, 2017 11:00-13:00 Registration Room: Hotel Lobby North/Assembly Foyer Room South Ballroom 13:00-13:15 Opening Remarks, Editorial Organizers 13:15-14:15 Opening Keynote: Anthony S. Fauci, NIAID, USA Emerging and Re-Emerging Infectious Diseases: From AIDS to Zika [KEY1] 14:15-17:45 Session 1: Genomics & Evolution Session Chair: Akiko Iwasaki, Yale University 14:15-14:45 George Fu Gao, Chinese Academy of Sciences, China Enveloped virus entry: From Flu to Ebola [INV01] 14:45-15:00 [ST01] Functional Evolution of Zika Virus in the Americas N.D. Grubaugh*, C. Ontiveros, R. Agarwal, T. Rogers, N. Beutler, K. Gangavarapu, G. Oliveira, R. Robles- Sikisaka, D. Burton, K.G. Andersen The Scripps Research Institute, USA 15:00-15:15 [ST02] Characterization of a clade-defining Ebola virus glycoprotein mutant from the 2013-2016 epidemic W.E. Diehl1, D. Mu1, A.E. Lin3, M. Cabot2, K.G. Andersen4, J.H. Kuhn6, P. Sabeti3, B. Ganser-Pornillos2, J. White2, J. Luban*1 et al 1University of Massachusetts Medical School, USA, 2University of Virginia, USA, 3Harvard University, USA, 4The Scripps Research Institute, USA, 5University of Edinburgh, UK, 6NIAID, USA 15:15-15:45 Gustavo Palacios, USAMRIID Center for Genomic Sciences, USA Near real-time genomics applications in clinical virology and biosurveillance [INV02] 15:45-16:15 Refreshment Break Room: North Ballroom 16:15-16:45 Linfa Wang, Duke-NUS Medical School, Singapore Programme in emerging infectious diseases [INV03] 16:45-17:00 [ST03] Immune correlates of protection from a universal influenza vaccine during intra- and intersubtypic heterologous challenge with H1, H6, H7 and H10 influenza viruses J.C. -
Virus Recognition by Toll-7 Activates Antiviral Autophagy in Drosophila
Immunity Article Virus Recognition by Toll-7 Activates Antiviral Autophagy in Drosophila Margaret Nakamoto,1,2 Ryan H. Moy,1,2 Jie Xu,1 Shelly Bambina,1 Ari Yasunaga,1 Spencer S. Shelly,1 Beth Gold,1 and Sara Cherry1,* 1Department of Microbiology, Penn Genome Frontiers Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA 2These authors contributed equally to this work *Correspondence: [email protected] DOI 10.1016/j.immuni.2012.03.003 SUMMARY tion molecules that activate a proteolytic cascade converging on the activation of spa¨ tzle, a cytokine that binds to Toll thereby Innate immunity is highly conserved and relies on inducing an NF-kB-dependent transcriptional program for anti- pattern recognition receptors (PRRs) such as Toll- microbial defense. Surprisingly, a role for the additional eight like receptors (identified through their homology to Drosophila Toll homologs in innate immune defense has yet to Drosophila Toll) for pathogen recognition. Although be established. Toll-2 (18-wheeler) may have a minor role in Drosophila Toll is vital for immune recognition and the antibacterial response (Ligoxygakis et al., 2002; Williams defense, roles for the other eight Drosophila Tolls in et al., 1997), and Toll-5 (Tehao) and Toll-9 can activate the expression of the antifungal gene Drosomycin (Bilak et al., immunity have remained elusive. Here we have 2003; Luo et al., 2001; Ooi et al., 2002; Tauszig et al., 2000). shown that Toll-7 is a PRR both in vitro and in adult However, these receptors have not been implicated as essential flies; loss of Toll-7 led to increased vesicular stoma- components of the immune response or in the recognition of any titis virus (VSV) replication and mortality. -
Endocytosis of Mosquito-Borne Flaviviruses
viruses Review Beyond the Surface: Endocytosis of Mosquito-Borne Flaviviruses Stephen D. Carro and Sara Cherry * Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; [email protected] * Correspondence: [email protected] Abstract: Flaviviruses are a group of positive-sense RNA viruses that are primarily transmitted through arthropod vectors and are capable of causing a broad spectrum of diseases. Many of the flaviviruses that are pathogenic in humans are transmitted specifically through mosquito vectors. Over the past century, many mosquito-borne flavivirus infections have emerged and re-emerged, and are of global importance with hundreds of millions of infections occurring yearly. There is a need for novel, effective, and accessible vaccines and antivirals capable of inhibiting flavivirus infection and ameliorating disease. The development of therapeutics targeting viral entry has long been a goal of antiviral research, but most efforts are hindered by the lack of broad-spectrum potency or toxicities associated with on-target effects, since many host proteins necessary for viral entry are also essential for host cell biology. Mosquito-borne flaviviruses generally enter cells by clathrin-mediated endocytosis (CME), and recent studies suggest that a subset of these viruses can be internalized through a specialized form of CME that has additional dependencies distinct from canonical CME pathways, and antivirals targeting this pathway have been discovered. In this review, we discuss the role and contribution of endocytosis to mosquito-borne flavivirus entry as well as consider past and future efforts to target endocytosis for therapeutic interventions. Keywords: flavivirus; mosquito-borne; clathrin-mediated; endocytosis; receptors; RNASEK; LY6E; Citation: Carro, S.D.; Cherry, S.